← Leaderboards
David H Walker
University Of Texas Medical Br Galveston
$27,320,724
Attributed
$30,766,620
Total exposure
24
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $13.6M · FY2005–18$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$133,743,073 · 26
By mechanism
U54$113,452,026 · 5
R01$15,274,429 · 3
D43$1,531,084 · 3
U01$1,328,512 · 2
R21$846,007 · 2
S10$709,590 · 3
Top collaborators
- Xiaodong Cheng5 shared
- Juan David Rodas2 shared
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Xue-Jie Yu$2,503,158
- Lynn Soong$9,725,492
- Ilya V. Frolov$8,182,660
- Scott C Weaver$56,593,623
- Gregory C. Lanzaro$14,378,012
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelRickettsiaInfectionProgramsInstitutionPathogenesisCellsCategoriesResponseBiodefenseGrantVaccinesPathogenDiagnosticBacteriaResearch Project GrantsDesignIn VivoCytokineFundingAnimalsNational Institute Of Allergy And Infectious DiseaseBaseRickettsia Infections
Grant awards (89)
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1$1,200,531
R01 · FY2018 · AI
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1$1,209,563
R01 · FY2017 · AI
Research Training Program on the Impact of Zoonotic and Vector-borne Viruses, Rickettsiae, and Leptospira in Acute Undifferentiated Febrile Illnesses$215,520
D43 · FY2017 · TW · contact PI
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1$1,256,218
R01 · FY2016 · AI
Research Training Program on the Impact of Zoonotic and Vector-borne Viruses, Rickettsiae, and Leptospira in Acute Undifferentiated Febrile Illnesses$216,000
D43 · FY2016 · TW · contact PI
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1$1,255,285
R01 · FY2015 · AI
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1$1,538,676
R01 · FY2014 · AI
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise$7,885,911
U54 · FY2013 · AI · contact PI
Career Development and Training Program$732,233
U54 · FY2013 · AI · contact PI
Administrative Core$703,744
U54 · FY2013 · AI · contact PI
Developmental Research Plan$660,190
U54 · FY2013 · AI · contact PI
Spotted Fever Rickettsial Antigens$351,225
R01 · FY2013 · AI · contact PI
Vector-host-pathogen interface in monocytotropic ehrlichiosis$179,775
R21 · FY2013 · AI · contact PI
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise$7,824,251
U54 · FY2012 · AI · contact PI
Administrative Core$620,713
U54 · FY2012 · AI · contact PI
Career Development and Training Program$583,920
U54 · FY2012 · AI · contact PI
Developmental Research Plan$442,541
U54 · FY2012 · AI · contact PI
Spotted Fever Rickettsial Antigens$373,680
R01 · FY2012 · AI · contact PI
Vector-host-pathogen interface in monocytotropic ehrlichiosis$229,500
R21 · FY2012 · AI · contact PI
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise$8,128,622
U54 · FY2011 · AI · contact PI
Career Development and Training Program$725,889
U54 · FY2011 · AI · contact PI
Administrative Core$652,485
U54 · FY2011 · AI · contact PI
Developmental Research Plan$602,580
U54 · FY2011 · AI · contact PI
Spotted Fever Rickettsial Antigens$373,714
R01 · FY2011 · AI · contact PI
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise$76,789
U54 · FY2011 · AI · contact PI
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise$7,686,492
U54 · FY2010 · AI · contact PI
Administrative Core$936,879
U54 · FY2010 · AI · contact PI
Developmental Research Plan$708,074
U54 · FY2010 · AI · contact PI
Career Development and Training Program$687,296
U54 · FY2010 · AI · contact PI
Spotted Fever Rickettsial Antigens$377,525
R01 · FY2010 · AI · contact PI
Ehrlichia chaffeensis protective proteins$347,626
R01 · FY2010 · AI · contact PI
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise$9,020,953
U54 · FY2009 · AI · contact PI
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise$932,328
U54 · FY2009 · AI · contact PI
Developmental Research Plan$728,262
U54 · FY2009 · AI · contact PI
Career Development and Training Program$721,955
U54 · FY2009 · AI · contact PI
Administrative Core$718,904
U54 · FY2009 · AI · contact PI
Spotted Fever Rickettsial Antigens$394,621
R01 · FY2009 · AI · contact PI
Ehrlichia chaffeensis protective proteins$351,137
R01 · FY2009 · AI · contact PI
Region VI Center for Biodefence and Emerging Infections$10,678,610
U54 · FY2008 · AI · contact PI
WRCE Administrative Core$604,703
U54 · FY2008 · AI · contact PI
Ehrlichia chaffeensis protective proteins$383,732
R01 · FY2008 · AI · contact PI
Spotted Fever Rickettesial Antigens$351,137
R01 · FY2008 · AI · contact PI
REGION VI RCE - NONHUMAN PRIMATE CORE$20,745
P51 · FY2008 · RR · contact PI
LASSA FEVER BIVALENT VACCINE EFFICACY IN MARMOSETS$6,471
P51 · FY2008 · RR · contact PI
EXPERIMENTAL INFECTION OF THE MARMOSET WITH LASSA VIRUS$2,728
P51 · FY2008 · RR · contact PI
LASSA FEVER VACCINE EFFICACY IN MARMOSETS$2,728
P51 · FY2008 · RR · contact PI
Region VI Center for Biodefence and Emerging Infections$10,700,953
U54 · FY2007 · AI · contact PI
Vaccine for Epidemic Typhus$460,372
U01 · FY2007 · AI · contact PI
Spotted Fever Rickettesial Antigens$357,938
R01 · FY2007 · AI · contact PI
Ehrlichia chaffeensis protective proteins$357,938
R01 · FY2007 · AI · contact PI
LASSA FEVER VACCINE EFFICACY IN MARMOSETS$241,714
P51 · FY2007 · RR · contact PI
REGION VI RCE - NONHUMAN PRIMATE CORE$144,999
P51 · FY2007 · RR · contact PI
Tropical Vector-borne Viral and Rickettsial Infections$133,950
D43 · FY2007 · TW · contact PI
Region VI Center for Biodefence and Emerging Infections$11,399,642
U54 · FY2006 · AI · contact PI
Vaccine for Epidemic Typhus$499,920
U01 · FY2006 · AI · contact PI
Ehrlichia chaffeensis protective proteins$368,629
R01 · FY2006 · AI · contact PI
Spotted Fever Rickettesial Antigens$368,629
R01 · FY2006 · AI · contact PI
Gammacell-220 Excel Refurbished Research Irradiator$354,795
S10 · FY2006 · RR · contact PI
GAMMACELL-220 EXCEL REFURBISHED RESEARCH IRRADIATOR: INFECTIOUS DISEASE$248,356
S10 · FY2006 · RR · contact PI
Tropical Vector-borne Viral and Rickettsial Infections$142,500
D43 · FY2006 · TW · contact PI
GAMMACELL-220 EXCEL REFURBISHED RESEARCH IRRADIATOR: BIODEFENSE$106,439
S10 · FY2006 · RR · contact PI
REGION VI RCE - NONHUMAN PRIMATE CORE$71,386
P51 · FY2006 · RR · contact PI
Region VI Center for Biodefence and Emerging Infections$12,477,542
U54 · FY2005 · AI
Spotted Fever Rickettesial Antigens$377,500
R01 · FY2005 · AI
Ehrlichia chaffeensis protective proteins$377,500
R01 · FY2005 · AI
Tropical Vector-borne Viral and Rickettsial Infections$150,000
D43 · FY2005 · TW
REGION VI RCE - NONHUMAN PRIMATE CORE$57,607
P51 · FY2005 · RR
Region VI Center for Biodefence and Emerging Infections$11,566,950
U54 · FY2004 · AI
Spotted Fever Rickettesial Antigens$377,500
R01 · FY2004 · AI
Ehrlichia chaffeensis Surface Proteins$372,500
R01 · FY2004 · AI
Tropical Vector-borne Viral and Rickettsial Infections$150,000
D43 · FY2004 · TW
CORE--REGION VI RCE - NONHUMAN PRIMATE CORE$53,047
P51 · FY2004 · RR
Region VI Center for Biodefence and Emerging Infections$4,242,615
U54 · FY2003 · AI
Ehrlichia chaffeensis Surface Proteins$372,500
R01 · FY2003 · AI
SPOTTED FEVER RICKETTSIAL ANTIGENS$372,500
R01 · FY2003 · AI
Tropical Vector-borne Viral and Rickettsial Infections$150,000
D43 · FY2003 · TW
Ehrlichia chaffeensis Surface Proteins$372,500
R01 · FY2002 · AI
SPOTTED FEVER RICKETTSIAL ANTIGENS$335,250
R01 · FY2002 · AI
EMERGING AND RE-EMERGING RICKETTSIOSES IN LATIN AMERICA$100,000
D43 · FY2002 · TW
SPOTTED FEVER RICKETTSIAL ANTIGENS$372,500
R01 · FY2001 · AI
Ehrlichia chaffeensis Surface Proteins$353,875
R01 · FY2001 · AI
EMERGING AND RE-EMERGING RICKETTSIOSES IN LATIN AMERICA$143,486
D43 · FY2001 · TW
COMPLETE GENOME SEQUENCE OF RICKETTSIA TYPHI$60,514
U01 · FY2001 · AI
EHRLICHIA CHAFFEENSIS SURFACE PROTEINS$372,500
R21 · FY2000 · AI
SPOTTED FEVER RICKETTSIAL ANTIGENS$372,500
R01 · FY2000 · AI
COMPLETE GENOME SEQUENCE OF RICKETTSIA TYPHI$307,706
U01 · FY2000 · AI
EMERGING AND RE-EMERGING RICKETTSIOSES IN LATIN AMERICA$118,288
D43 · FY2000 · TW
EHRLICHIA CHAFFEENSIS SURFACE PROTEINS$64,232
R21 · FY2000 · AI
EMERGING AND RE-EMERGING RICKETTSIOSES IN LATIN AMERICA$11,340
D43 · FY2000 · TW